Initiation of buprenorphine during incarceration and retention in treatment upon release |
| |
Authors: | Nickolas Zaller Michelle McKenzie Peter D Friedmann Traci C Green Samuel McGowan Josiah D Rich |
| |
Institution: | 1. The Miriam Hospital, Providence, RI, USA;2. The Warren Alpert Medical School of Brown University, Providence, RI, USA;3. Rhode Island Hospital, Providence, RI, USA |
| |
Abstract: | We report here on a feasibility study of initiating buprenorphine/naloxone prior to release from incarceration and linking participants to community treatment providers upon release. The study consisted of a small number of Rhode Island (RI) prisoners (N = 44) diagnosed with opioid dependence. The study design is a single arm, open-label pilot study with a 6-month follow up interview conducted in the community. However, a natural experiment arose during the study comparing pre-release initiation of buprenorphone/naloxone to initiation post-release. Time to post-release prescriber appointment (mean days) for initiation of treatment outside Rhode Island Department of Corrections (RIDOC) versus inside RIDOC was 8.8 and 3.9, respectively (p = .1). Median post release treatment duration (weeks) for outside RIDOC versus inside RIDOC was 9 and 24, respectively (p = .007). We conclude that initiating buprenorphine/naloxone prior to release from incarceration may increase engagement and retention in community-based treatment. |
| |
Keywords: | Buprenorphine/naloxone Incarceration Opiates Addiction HIV |
本文献已被 ScienceDirect 等数据库收录! |
|